Pluri Inc. (NASDAQ:PLUR) Short Interest Update

Pluri Inc. (NASDAQ:PLUR) was the recipient of a large growth in short interest in the month of December. As of December 15th, there was short interest totalling 10,100 shares, a growth of 18.8% from the November 30th total of 8,500 shares. Approximately 0.3% of the shares of the company are short sold. Based on an average trading volume of 25,800 shares, the short-interest ratio is presently 0.4 days.

Pluri Stock Performance

Shares of PLUR stock traded down $0.03 during trading hours on Tuesday, hitting $4.28. 8,906 shares of the company were exchanged, compared to its average volume of 18,271. Pluri has a 52-week low of $4.07 and a 52-week high of $8.48. The company has a current ratio of 5.90, a quick ratio of 5.90 and a debt-to-equity ratio of 4.44. The firm has a fifty day simple moving average of $4.89 and a 200 day simple moving average of $5.23. The stock has a market capitalization of $23.79 million, a price-to-earnings ratio of -0.71 and a beta of 1.64.

Pluri Company Profile

Pluri Inc, a biotechnology company, engages in the development of placenta-based cell therapy product candidates for the treatment of inflammatory, muscle injuries, and hematologic conditions. It operates in the field of regenerative medicine, food-tech, and biologics and focuses on establishing partnerships that leverage its 3D cell-based technology to additional industries that require mass cell production.